Mechanistically, NRF2 suppresses IPMN formation through redox-independent transcriptional repression of SAM pointed domain–containing Ets transcription factor and MUC6, key markers of IPMN. The gene discussed is MUC6; the disease is pancreatic intraductal papillary-mucinous neoplasm.